MétaCan
Menu
Back to cohort
Record W3038493324

Plk1 - A novel therapeutic target for nasopharyngeal carcinoma

2007· article· en· W3038493324 on OpenAlexaff
Wei Shi, Carlo Bastianutto, Nehad M. Alajez, Angela Bik‐Yu Hui, Fei‐Fei Liu

Bibliographic record

VenueCancer Research · 2007
Typearticle
Languageen
FieldMedicine
TopicCancer-related Molecular Pathways
Canadian institutionsOntario Institute for Cancer Research
Fundersnot available
KeywordsNasopharyngeal carcinomaPLK1BiologyCyclin B1Cancer researchCell cycleViability assayMitosisSmall interfering RNAPopulationCell cycle checkpointApoptosisCyclin-dependent kinase 1Cell cultureMedicineCell biologyInternal medicineTransfectionRadiation therapyBiochemistryGenetics
DOInot available

Abstract

fetched live from OpenAlex

5390 Introduction Polo-like kinase 1 (PLK1) is a critical regulator of the many stages of mitosis. Accumulating evidence indicates that over-expression of Plk1 correlates with clinical outcome. In this work, we evaluate for the first time, the expression of Plk1 in primary human nasopharyngeal carcinoma (NPC) biopsies, and demonstrate its potential role as a therapeutic target. Experimental Procedures Plk1 expression was assessed using immunohistochemistry in 40 NPC archival samples linked to outcome data. Plk1 was targeted using siRNA to evaluate both functional significance, as well as its therapeutic potential in NPC. RNA interference was achieved using a pooled small interfering RNA (siPlk1) to knock down the expression of PLK1 in the Epstein-Barr Virus (EBV)-positive NPC cell line C666-1. Results Plk1 immunoexpression was observed in 28 of 40 specimens (70%), which in turn, was associated with a higher likelihood of recurrence (p=0.018). SiPlk1 (30nM) reduced C666-1 viability in a time and dose-dependent manner. The cytotoxic effect was enhanced with the addition of radiation (6 Gy), down to 15% viability at day 7. This cytotoxicity appeared to be mediated by apoptosis (33.5% at 48 hours), along with activation of caspases 3/7 (2.1-fold increase over control). Cell cycle analysis demonstrated an increase in the G2/M cell population to 30.6%. Immunofluorescence demonstrated the G2/M arrest being associated with aberrant spindle formation, resulting in mitotic arrest.Western blotting corroborated that down-regulation of Plk1 was associated with an increase in Cyclin B1 expression, consistent with the known downstream targets of Plk1. Finally, the therapeutic potential of Plk1 was assessed using an in vivo tumor-formation assay. Transfection of C666-1 cells with SiPlk1 delayed tumor formation by 44 days, compared to control mice. When combined with radiation (6 Gy), this resulted in a further delay in tumor development of up to 75 days, compared to the 60 days in the siCNTR-treated group. Conclusion Our data demonstrate over-expression of Plk1 in human NPC samples, which was associated with a higher risk of recurrent disease. In addition, targeting Plk1 was effective in reducing NPC survival both in vitro and in vivo, particularly when combined with ionizing radiation, indicating that Plk1 likely represents an important target for NPC therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.125
GPT teacher head0.427
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2007
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicCancer-related Molecular PathwaysFrench-language works237,207